# A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery

> **NCT04557189** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 89 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting (PONV)

## Interventions

- **DRUG:** TAK-951
- **DRUG:** Ondansetron
- **DRUG:** Ondansetron Placebo
- **DRUG:** TAK-951 Placebo

## Key facts

- **NCT ID:** NCT04557189
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-20
- **Primary completion:** 2022-03-07
- **Final completion:** 2022-03-21
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04557189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04557189, "A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04557189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*